Transgenic expression of ALOX15 suppresses TNF-α and iNOS expression as well as NF-κB activation and downregulates LRP5 to suppress Wnt/β-catenin signaling, thereby inhibiting colon cancer [79,80]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.